Wegovy是新加坡为12岁及12岁以上人士提供的每周新注射的肥胖症注射。 Wegovy, a new weekly injectable for obesity, becomes available in Singapore for those 12 and older.

Wegovy (semaglutide 2.4mg)是针对肥胖和超重的一周一次的注射治疗,目前在新加坡为12岁及以上的成人和青少年提供。 Wegovy® (semaglutide 2.4mg), a once-weekly injectable treatment for obesity and overweight, is now available in Singapore for adults and adolescents aged 12 and above. 它有助于减少食物摄取量,并在减少卡路里饮食和增加体力活动的同时支持减肥。 It helps reduce food intake and support weight loss when combined with a reduced-calorie diet and increased physical activity. 然而,Rowan French博士警告说,Wegovy不应被视为一种奇迹疗法,应该与改变生活方式和提供营养支持同时使用。 However, Dr. Rowan French warns that Wegovy should not be seen as a miracle cure and should be used alongside lifestyle changes and nutritional support. 他强调,肥胖是一个复杂的终身问题,需要采取全面办法才能长期取得成功。 He emphasizes that obesity is a complex, lifelong issue that requires a comprehensive approach for long-term success.